Eight entities from seven regions of SUDOE worked with the common challenge of innovating in the field of the detection and treatment of early hearing loss: combining knowledge and technology to move from a medicine based on the treatment of symptoms to a personalized medicine and focused on combat the problem. Approximately 60% to 80% of deafness is genetic in origin. Incorporating genetic diagnosis into current programmes for the early detection of hearing loss is key both for the diagnosis of the disease and for predicting its nature, evolution and establishing personalised treatments.
- The GHELP genetic diagnostic panel for hearing loss.
- The economic feasibility study of implementation
- The training materials aimed at ENT specialists
- A guide for parents to understand the genetic basis of deafness.
The event will take place on 24 September at 12am. Click here to go to the Zoom link.